Study on Zanidatamab with Cisplatin and Gemcitabine for Advanced HER2 Positive Biliary Tract Cancer Patients
- Substances:CisplatinDurvalumab+3
Finland- Participants:18–64 years · 65+ years
- Substances:Cisplatin
Rare diseases
Investigational molecules
Locations
FinlandStudy Comparing Inotuzumab Ozogamicin to Drug Combination for Children with High-Risk Relapsed B-cell Acute Lymphoblastic Leukemia
FinlandStudy on the Effects of Ticagrelor and Rivaroxaban in Patients with Atrial Fibrillation After Coronary Stent Surgery
FinlandStudy on the Impact of Exercise and Atorvastatin on Advanced Breast, Ovarian, Prostate, and Kidney Cancer Patients
FinlandStudy on the Effectiveness of [18F]FAPI-74 PET/CT for Detecting Lymph Node Spread in Patients with Pancreatic Cancer
FinlandStudy of 18F-FAPI-74 PET/CT Imaging for Detection of Lymph Node Metastases in Patients with Colon Cancer
FinlandStudy on Emicizumab and Drug Combination for Patients with Haemophilia A and FVIII Inhibitors
FinlandStudy of azacitidine combined with low-dose venetoclax treatment for patients with acute myeloid leukemia
FinlandPrevention of Infantile Spasms with Vigabatrin in High-Risk Children Under 1 Year Old: A Study for Patients with Tuberous Sclerosis or Large Vascular Brain Injury
FinlandStudy on Muscle Relaxation Reappearance in Patients Under General Anesthesia Using Glycopyrronium Bromide and Neostigmine Methylsulfate
FinlandStudy comparing BCG and combination of BCG with electromotive mitomycin-C treatment in patients with high-risk non-muscle-invasive bladder cancer
FinlandStudy on Capecitabine and Oxaliplatin for High-Risk Rectal Cancer Patients to Reduce Metastases
FinlandTell us about your condition – we search every trial in Europe and connect you with the right site.